Download presentation
Presentation is loading. Please wait.
Published byKelly Wilkinson Modified over 6 years ago
1
Remission and time of resolution of nail psoriasis during infliximab therapy
Luca Bianchi, MD, Antonio Bergamin, MD, Catia de Felice, MD, Elisabetta Capriotti, MD, Sergio Chimenti, MD Journal of the American Academy of Dermatology Volume 52, Issue 4, Pages (April 2005) DOI: /j.jaad Copyright © 2005 American Academy of Dermatology, Inc. Terms and Conditions
2
Fig 1 Mean NAPSI variations of group I and II against time. Infliximab induced a progressive clinical improvement of nail psoriasis at the dosage of 5 mg/kg as shown by the statistically significant (P < .0001) reduction of NAPSIm from baseline to week 22. Journal of the American Academy of Dermatology , DOI: ( /j.jaad ) Copyright © 2005 American Academy of Dermatology, Inc. Terms and Conditions
3
Fig 2 Clinical picture of nail psoriasis of fingernails before (a) and after (b) treatment with infliximab at 22 weeks. Journal of the American Academy of Dermatology , DOI: ( /j.jaad ) Copyright © 2005 American Academy of Dermatology, Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.